DK0593585T3 - Peptid, som modvirker TNF- og LPS-toksicitet - Google Patents

Peptid, som modvirker TNF- og LPS-toksicitet

Info

Publication number
DK0593585T3
DK0593585T3 DK92914507T DK92914507T DK0593585T3 DK 0593585 T3 DK0593585 T3 DK 0593585T3 DK 92914507 T DK92914507 T DK 92914507T DK 92914507 T DK92914507 T DK 92914507T DK 0593585 T3 DK0593585 T3 DK 0593585T3
Authority
DK
Denmark
Prior art keywords
counteracts
tnf
peptide
lps toxicity
lps
Prior art date
Application number
DK92914507T
Other languages
English (en)
Inventor
Deborah Ann Rathjen
Geoffrey Walter Grigg
Philip On-Lok Mack
Fred Widmer
Original Assignee
Peptech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peptech Ltd filed Critical Peptech Ltd
Application granted granted Critical
Publication of DK0593585T3 publication Critical patent/DK0593585T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/525Tumour necrosis factor [TNF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK92914507T 1991-07-05 1992-07-03 Peptid, som modvirker TNF- og LPS-toksicitet DK0593585T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPK709791 1991-07-05
AUPK792491 1991-08-22
PCT/AU1992/000332 WO1993001211A1 (en) 1991-07-05 1992-07-03 Peptide which abrogates tnf and/or lps toxicity

Publications (1)

Publication Number Publication Date
DK0593585T3 true DK0593585T3 (da) 2002-08-19

Family

ID=25644068

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92914507T DK0593585T3 (da) 1991-07-05 1992-07-03 Peptid, som modvirker TNF- og LPS-toksicitet

Country Status (7)

Country Link
US (1) US5795859A (da)
EP (1) EP0593585B1 (da)
JP (1) JP3534748B2 (da)
CA (1) CA2112907C (da)
DE (1) DE69232586T2 (da)
DK (1) DK0593585T3 (da)
WO (1) WO1993001211A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587457A (en) * 1990-03-12 1996-12-24 Peptide Technology Limited Neutrophil stimulating peptides
US6375928B1 (en) * 1990-03-12 2002-04-23 Peptech Limited Neutrophil stimulating peptides
IT1254315B (it) * 1992-03-27 1995-09-14 Mini Ricerca Scient Tecnolog Anticorpi monoclonali anti-idiotipici diretti contro anticorpi anti-tnf.
US5457129A (en) * 1993-05-17 1995-10-10 Research Development Foundation Inhibition of nitric oxide production by retinoic acid
US6107273A (en) * 1995-01-24 2000-08-22 Thomas Jefferson University Tumor necrosis factor inhibitors
US6107457A (en) * 1995-02-16 2000-08-22 Board Of Regents, The University Of Texas System Bcr-Abl directed compositions and uses for inhibiting Philadelphia chromosome stimulated cell growth
US6803044B1 (en) 1999-03-24 2004-10-12 Zengen, Inc. Antimicrobial and anti-inflammatory peptides for use in human immunodeficiency virus
US6800291B1 (en) * 1999-03-24 2004-10-05 Zengen, Inc. Uro-genital condition treatment system
US7402559B2 (en) 1999-03-24 2008-07-22 Msh Pharma, Incorporated Composition and method of treatment for urogenital conditions
US7244710B2 (en) * 2002-05-21 2007-07-17 Zengen, Inc. Treatment of ophthalmic infections using antimicrobial peptides
US20040220103A1 (en) * 1999-04-19 2004-11-04 Immunex Corporation Soluble tumor necrosis factor receptor treatment of medical disorders
AU2001297591A1 (en) * 2000-11-01 2002-09-19 Zengen, Inc. A sunburn treatment and sunburn prevention method
US6780838B2 (en) 2001-01-29 2004-08-24 Zengen, Inc. Compounds for treating fungal pathologies of the oral cavity
US6894028B2 (en) 2001-04-06 2005-05-17 Zengen, Inc. Use of KPV tripeptide for dermatological disorders
US7115574B2 (en) 2001-12-10 2006-10-03 Zengen, Inc. System and method for support legacy operating system booting in a legacy-free system
US6939846B2 (en) 2001-12-17 2005-09-06 Zengen, Inc. Use of a polypeptide for treatment of pruritis in animals
US7892563B2 (en) 2003-05-20 2011-02-22 Wyeth Holdings Corporation Methods for treatment of severe acute respiratory syndrome (SARS)
CN1960744A (zh) * 2004-02-27 2007-05-09 瓦克斯咨询公司 肽IL1β和TNFα以及应用其治疗的方法
WO2007009233A2 (en) * 2005-07-18 2007-01-25 University Of Manitoba Peptide-based cytokine vaccines in the treatment of autoimmune and inflammatory diseases
AU2014215639B2 (en) * 2013-01-25 2017-03-23 Thymon, Llc Compositions for selective reduction of circulating bioactive soluble TNF and methods for treating TNF-mediated disease

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB313654A (en) * 1928-03-16 1929-06-17 Shell Mex Ltd Improvements in or relating to plug cocks
US4508728A (en) * 1984-05-24 1985-04-02 Kineshiro Nagai Method of treating inflammatory diseases
JPS61186322A (ja) * 1985-02-13 1986-08-20 Nippon Univ 免疾調節剤
JPH07116160B2 (ja) * 1987-08-10 1995-12-13 浜理薬品工業株式会社 結晶性l−カルノシン亜鉛錯体およびその製造法
JP2828988B2 (ja) * 1988-04-03 1998-11-25 源一郎 杣 新規dnaとその生産方法、それを有する新規プラスミド、新規ポリペプチドとその生産方法、及び該ポリペプチドからなる新規抗腫瘍剤
DE3817955A1 (de) * 1988-05-27 1989-11-30 Hoechst Ag Tnf-inhibitor enthaltendes arzneimittel
EP0436611A4 (en) * 1988-09-28 1992-03-11 Peptide Technology Ltd Compound and method for the retardation of collagen cross-linking
DE3841767A1 (de) * 1988-12-12 1990-06-13 Basf Ag Neue tnf-peptide
DE3841755A1 (de) * 1988-12-12 1990-06-13 Basf Ag Neue tnf-peptide
JP3443119B2 (ja) * 1989-08-07 2003-09-02 ペプテック リミテッド 腫瘍壊死因子結合リガンド
EP0491878B1 (en) * 1989-08-16 1997-02-19 Chiron Corporation Compositions for the inhibition of protein hormone formation and uses thereof
GB9028123D0 (en) * 1990-12-28 1991-02-13 Erba Carlo Spa Monoclonal antibodies against human tumor necrosis factor alpha
CA2139127A1 (en) * 1992-06-25 1994-01-06 Chiron Corporation Compositions for the inhibition of protein hormone formation and uses thereof

Also Published As

Publication number Publication date
CA2112907C (en) 2003-09-23
EP0593585A4 (en) 1995-01-18
CA2112907A1 (en) 1993-01-21
JP3534748B2 (ja) 2004-06-07
AU673332B2 (en) 1996-11-07
DE69232586D1 (de) 2002-06-06
DE69232586T2 (de) 2002-11-28
US5795859A (en) 1998-08-18
EP0593585B1 (en) 2002-05-02
AU2273192A (en) 1993-02-11
WO1993001211A1 (en) 1993-01-21
EP0593585A1 (en) 1994-04-27
JPH07502978A (ja) 1995-03-30

Similar Documents

Publication Publication Date Title
DK0593585T3 (da) Peptid, som modvirker TNF- og LPS-toksicitet
FI921233L (fi) Bestaemning av kenresorption med hjaelp av en peptid som frigoers naer kollagen nedbryts
NO942066D0 (no) Peptidderivater
FI921125A0 (fi) Ciclosporin.
FI941398A0 (fi) Modifioituja peptidijohdannaisia
FI923494L (fi) Peptidylderivat.
NO941629D0 (no) Peptider som inhiberer 1L-1
FI922958A0 (fi) Farmaceutisk sammansaettning.
FI921060A0 (fi) Farmaceutiska aerosolformuleringar.
FI922316A0 (fi) Farmaceutisk sammansaettning.
FI922252A0 (fi) Farmaceutisk sammansaettning.
DK0503939T3 (da) Antimikrobielt peptid og antimikrobielt middel.
FI921182A0 (fi) Velangummi som snabbt hydratiseras.
FI924759A7 (fi) Tvaopipigt eldvapen som kan avfyras flera gaonger
FI920271L (fi) Polyamintioler som straolningsskyddande aemnen.
FI941758L (fi) Rekombitooppipeptidejä
FI923238A0 (fi) Cysteinamid innehaollande permanent.
TR28651A (tr) Cam terkibi ve kullanilmasi.
FI941859A7 (fi) Kopolymer användbar som viskositetsindexförbättrande tillsatsmedel för hydraulvätska
FI914926A0 (fi) Poly(aryleter)skum producerat med vattenhaltigt expansionsmedel.
FI934717A0 (fi) Genexpression i bacillus
FI920456L (fi) Msh-peptidderivator.
EP0605561A4 (en) ANNEXIN-XI.
FI924395L (fi) Icke-a, icke-b-peptider
EP0672680A4 (en) NEW PEPTIDE.